Equities Analysts Offer Predictions for Revvity Q2 Earnings

Revvity Inc. (NYSE:RVTY - Free Report) - Equities researchers at Leerink Partnrs increased their Q2 2025 EPS estimates for Revvity in a report issued on Thursday, July 17th. Leerink Partnrs analyst P. Souda now forecasts that the company will earn $1.15 per share for the quarter, up from their prior estimate of $1.14. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's FY2025 earnings at $4.94 EPS.

A number of other research firms have also recently issued reports on RVTY. Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a report on Friday. Robert W. Baird dropped their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Evercore ISI dropped their price objective on Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. JPMorgan Chase & Co. dropped their price objective on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Finally, The Goldman Sachs Group lowered their price target on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Five equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, Revvity presently has an average rating of "Moderate Buy" and a consensus target price of $123.07.

Revvity Stock Performance

RVTY traded down $2.39 during trading on Friday, reaching $93.19. 1,006,728 shares of the company's stock were exchanged, compared to its average volume of 976,770. Revvity has a fifty-two week low of $87.70 and a fifty-two week high of $129.50. The company has a quick ratio of 2.99, a current ratio of 3.58 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average price of $95.10 and a 200 day moving average price of $103.97. The company has a market capitalization of $10.98 billion, a P/E ratio of 39.66, a PEG ratio of 2.41 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The company's quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 earnings per share.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of RVTY. Optiver Holding B.V. bought a new position in shares of Revvity during the 4th quarter worth $33,000. Quarry LP boosted its position in shares of Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Revvity during the 4th quarter valued at about $38,000. UMB Bank n.a. boosted its position in shares of Revvity by 138.8% during the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company's stock valued at $39,000 after acquiring an additional 236 shares during the last quarter. Finally, Vermillion Wealth Management Inc. bought a new stake in shares of Revvity during the 4th quarter valued at about $41,000. Institutional investors own 86.65% of the company's stock.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. Revvity's dividend payout ratio is currently 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.